学术会议:紧随研究趋势 洞察学术热点 进入>
产业会议:新技术,新领域,深入产业环节 进入>
举办会议及论坛超过百场 邀请海内外院士超过50名 教授PI专家授课超过1000名 总参会人数超过10万人
2018-11-23至2018-11-24 上海
导航

拟邀嘉宾Guests to Be Invited

Matthias T. Stephan Assistant Member

Fred Hutchinson Cancer Research Center

Matthias T. Stephan Assistant Member

Fred Hutchinson Cancer Research Center

Appointments and Affiliations


Fred Hutchinson Cancer Research Center
Clinical Research Division
Program in Immunology
Assistant Member, Appointed: 2012

 

University of Washington
School of Medicine
Medical Oncology
Assistant Professor, Appointed: 2012

Degrees

Ph.D., Cornell University, Immunology, 2007

M.D., Medical University of Luebeck (Germany), 2002

Research Interests

The work of Dr. Stephan’s laboratory is conducted where materials science interfaces with immunology, and focuses on the design of synthetic materials that provide novel therapies to treat cancer. His premise, based on observations that certain immune cells can selectively destroy cancerous cells without damaging healthy ones, is that bioengineering approaches grounded in immunology may hold the key to discovering safer, more effective ways to treat cancer. He consequently takes a materials-centric engineering approach to create treatment strategies that are based on controlled modulation of the immune system.

Dr. Stephan’s goal is to make immunomodulation therapy more practical and widespread by creating off-the-shelf reagents that rapidly boost the body's natural ability to fight cancer. Thus, his research group seeks to translate immunomodulatory synthetic materials into the routine standard-of-care for cancer patients, and thereby shift the focus from harmful, broad-impact chemotherapy and radical surgery to the much more specific approach of immunotherapeutics.

Research efforts in the Stephan laboratory are currently focused on (1) the development of an implantable device to eradicate tumor cells left behind after surgery, and (as outlined in this proposal) (2) the design of polymeric nanoparticles that can rapidly program tumor-recognizing capabilities into lymphocytes in vivo.

Memberships

2014, Associate Scientific Advisor, Science Translational Medicine

2013, Member, Biomedical Engineering Society (BMES)

2013, Member, Fred Hutchinson/University of Washington Cancer Consortium

2012, Member, American Association for Cancer Research (AACR)

2012, Member, International Society for Cellular Therapy (ISCT)

Honors and Awards

2015, CAREER Award, National Science Foundation (NSF)

2014, Liz Tilberis Early Career Award, Ovarian Cancer Research Fund

2014, Young Investigator Award, Prostate Cancer Foundation

2014, Young Investigator Award, Melanoma Research Alliance

2014, New Idea Award, The Leukemia and Lymphoma Society

2010, Future Leaders in Translational Research Award, American Association for Cancer Research

2010, National Research Service Award, National Institute of Biomedical Imaging and Bioengineering

Previous Positions

2008-2012, Fellowship in Bioengineering, Massachusetts Institute of Technology

邀请函

下载邀请函
×
留下姓名电话和邮箱,邀请函直接发送到邮箱
*姓名:
* 电话:
* Email: